GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (LSE:VRCI) » Definitions » Asset Turnover

Verici Dx (LSE:VRCI) Asset Turnover : 0.34 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Verici Dx Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Verici Dx's Revenue for the six months ended in Jun. 2024 was £2.62 Mil. Verici Dx's Total Assets for the quarter that ended in Jun. 2024 was £7.70 Mil. Therefore, Verici Dx's Asset Turnover for the quarter that ended in Jun. 2024 was 0.34.

Asset Turnover is linked to ROE % through Du Pont Formula. Verici Dx's annualized ROE % for the quarter that ended in Jun. 2024 was -40.14%. It is also linked to ROA % through Du Pont Formula. Verici Dx's annualized ROA % for the quarter that ended in Jun. 2024 was -27.54%.


Verici Dx Asset Turnover Historical Data

The historical data trend for Verici Dx's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Asset Turnover Chart

Verici Dx Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Asset Turnover
- - - 0.09

Verici Dx Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Asset Turnover Get a 7-Day Free Trial - - - 0.12 0.34

Competitive Comparison of Verici Dx's Asset Turnover

For the Diagnostics & Research subindustry, Verici Dx's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verici Dx's Asset Turnover Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Verici Dx's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Verici Dx's Asset Turnover falls into.



Verici Dx Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Verici Dx's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.8/( (11.744+5.88)/ 2 )
=0.8/8.812
=0.09

Verici Dx's Asset Turnover for the quarter that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=2.624/( (5.88+9.515)/ 2 )
=2.624/7.6975
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Verici Dx  (LSE:VRCI) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Verici Dx's annulized ROE % for the quarter that ended in Jun. 2024 is

ROE %**(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=-2.12/5.281
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-2.12 / 5.248)*(5.248 / 7.6975)*(7.6975/ 5.281)
=Net Margin %*Asset Turnover*Equity Multiplier
=-40.4 %*0.6818*1.4576
=ROA %*Equity Multiplier
=-27.54 %*1.4576
=-40.14 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Verici Dx's annulized ROA % for the quarter that ended in Jun. 2024 is

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-2.12/7.6975
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-2.12 / 5.248)*(5.248 / 7.6975)
=Net Margin %*Asset Turnover
=-40.4 %*0.6818
=-27.54 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Verici Dx Asset Turnover Related Terms

Thank you for viewing the detailed overview of Verici Dx's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Verici Dx Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies that will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, which of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx Headlines

No Headlines